Commemorating 25 years of fighting pancreatic cancer
Learn More

Hirshberg Foundation for Pancreatic Cancer Research

Dedicated to advancing pancreatic cancer research and providing support to patients and their families.

Donate
  • ABOUT THE FOUNDATION
    • Agi’s Story
    • About Us →
      • Mission
      • Directors/Trustees
      • Scientific Advisory Board
      • How Our Journey Began
    • COVID-19 Resources
    • News →
      • Latest News
      • Research News
      • Foundation News
      • UCLA Activity Summary Reports
      • Newsletters
      • Press Room
    • Contact
  • PANCREATIC CANCER
    • About the Pancreas →
      • The Pancreas
      • Cancer Cells
      • Risk Factors
      • Symptoms
      • Diagnosis
      • Prognosis
      • Staging
      • Second Opinion
    • Treatment Options →
      • Surgery
      • Chemotherapy
      • Targeted Therapy
      • Radiation Therapy
      • Alternative Treatment Options
      • Clinical Trials
    • Supportive Care →
      • Obstructions
      • Pain Control
      • Nutrition
      • Cannabis
      • Palliative Care
    • Pancreatic Cancer Facts
    • Glossary of Terms
    • Frequently Asked Questions
  • RESEARCH
    • Seed Grant Program →
      • Seed Grant Recipients
      • Frequently Asked Questions
    • UCLA Program →
      • UCLA Center for Pancreatic Diseases
      • Basic Research
      • Translational Research
      • Sahin-Toth Laboratory
      • UCLA Pancreas Tissue Bank
      • UC Pancreatic Cancer Consortium
      • Simms/Mann Psychosocial →
        • Insights into Cancer
    • American Pancreatic Association
    • NIH Funded Projects
  • PATIENTS & CAREGIVERS
    • Patient Support
    • Caregivers
    • Symposium →
      • Symposium Presentations
    • Patient & Family Webinars
    • Genetic Counseling
    • Financial Aid
    • Resources →
      • Symptom Management Workbook
      • Guidelines for Patients: Pancreatic Cancer
      • Creating Your Health Care Team
      • A Virtual Advocate
      • Patient Tools
  • HOW YOU CAN HELP
    • You Can Help Funds
    • Host Your Own Event
    • Event Calendar
    • Get Inspired
    • November Awareness Month →
      • World Pancreatic Cancer Day
    • Other Ways to Give →
      • Shop Online Store
      • Wedding Program
      • Volunteer
      • Planned Giving
      • Car Program
  • SEARCH
Home / Research / Seed Grant Program / Seed Grant Recipients / Brian Boone, MD

Brian Boone, MD

Brian Boone, MD
Brian Boone, MD
Assistant Professor

Division of Surgical Oncology
Dept of Microbiology, Immunology and Cell Biology

West Virginia University
Morgantown, WV

Targeting Peptidyl Arginine Deiminase 4 (PAD4) Induced Neutrophil Extracellular Trap (NET) Formation to Enhance T cell Response in Pancreatic Adenocarcinoma

Overview

Aim: Basic Science / Cancer Biology

Pancreatic cancer is an aggressive disease characterized by inability of the immune system to fight the tumor. We have identified a process in pancreatic cancer, neutrophil extracellular trap formation (NETs) that may play a critical role in this weakened immune response. NETs occur when specific immune cells, neutrophils, become activated and expel all their contents outside the cell. This forms a web of DNA and other materials that contributes to the growth of tumor cells. We have recently discovered that mice incapable of forming NETs due to genetic deletion of PAD4, a critical part of the NET machinery, have decreased pancreatic tumor growth. Fortunately, there are specific drugs that target NETs and PAD4, known as PAD4 inhibitors. Our goal is to test these drugs in animal models of pancreatic cancer to determine if they can prevent tumor growth and the spread of the cancer to other organs. These valuable studies are the first step towards the potential for PAD4 inhibitors to be used as novel treatment in patients with pancreatic cancer at a time when new approaches are desperately needed. In addition to determining the efficacy of PAD4 inhibitors, we will also study how the drugs impact the body’s immune response to the tumor. We believe that by inhibiting PAD4/NETs, we will activate the immune system to fight the cancer. These studies will improve our understanding about how PAD4/NETs function and potentially lead to novel combination therapies with other new drugs that also augment the immune response.

Research

  • Seed Grant Program
    • Seed Grant Recipients
      • Alexandra Demcsak M.D., Ph.D.
      • Evan R. Abt, Ph.D.
      • Jason Link, Ph.D.
      • Kamini Singh Ph.D.
      • Ethan V Abel, PhD
      • Michael Feigin, Ph.D.
      • Mirunalini Ravichandran, Ph.D.
      • Simon Schwörer, Ph.D.
      • Vanaja Konduri, Ph.D.
    • Frequently Asked Questions
  • UCLA Program
    • UCLA Center for Pancreatic Diseases
    • Basic Research
    • Translational Research
    • Sahin-Toth Laboratory
    • UCLA Pancreas Tissue Bank
    • UC Pancreatic Cancer Consortium
    • Psychosocial Care via Simms/Mann
      • Insights into Cancer
  • American Pancreatic Association (APA)
  • NIH Funded Projects

Patient Support Resources

from the comfort of your home


Our Webinar Library »

Never Give Up.
The journey continues with an end in sight.
Our Stories »
SUBSCRIBE
Our Free E-Newsletter
Sign up to receive information on breaking news, patient programs and upcoming events.
You can custom tailor your subscriptions and unsubscribe at any time.
  • How You Can Help
  • Make A Donation
  • Host an Event
  • Shop Online Store
  • Signature Events
  • L.A. Cancer Challenge
  • Tour De Pier
  • Hirshberg Training Team
  • More
  • News
  • Press
  • Contact

Stay Connected

Join Our E-newsletter

  • Legal and Privacy
  • Contact Us